978-5-907561-33-5 10.31483/a-10364 Фундаментальные и прикладные исследования по приоритетным направлениям биоэкологии и биотехнологии Fundamental and applied research for key propriety areas of bioecology and biotechnology

В сборнике представлены статьи участников V Всероссийской научно-практической конференции с международным участием «Фундаментальные и прикладные исследования по приоритетным направлениям биоэкологии и биотехнологии». В материалах сборника приведены результаты теоретических и прикладных изысканий представителей научного и образовательного сообщества в области биологии и медицины.

 chief_editor Антонова Елена Ивановна Antonova Elena Ivanovna https://orcid.org/0000-0002-3686-9686 antonov_67@mail.ru Ленгесова Наталья Анатольевна Lengesova Natal'ia Anatol'evna https://orcid.org/0000-0001-7512-6386 lengesova@yandex.ru Антонова Елена Ивановна Antonova Elena Ivanovna https://orcid.org/0000-0002-3686-9686 Антонова Елена Ивановна Antonova Elena Ivanovna https://orcid.org/0000-0002-3686-9686 Ленгесова Наталья Анатольевна Lengesova Natal'ia Anatol'evna https://orcid.org/0000-0001-7512-6386 Беззубенкова Ольга Евгеньевна Bezzubenkova Ol'ga Evgen'evna https://orcid.org/0000-0002-3243-6381 Коняев Игорь Сергеевич Koniaev Igor' Sergeevich Масленников Андрей Викторович Maslennikov Andrei Viktorovich https://orcid.org/0000-0002-1421-7484 Куницына Анастасия Владимировна Khambikova Anastasiia Vladimirovna Фундаментальные и прикладные исследования по приоритетным направлениям биоэкологии и биотехнологии Fundamental and applied research for key propriety areas of bioecology and biotechnology 20 05 2022 Ульяновск ИД «Среда» 2022 Copyright © Куницына А. В., Антонова Е. И., Давидюк Ю. Н., Королева А. К., Ачилов А. Б., 2022 2022 This work is licensed under a Creative Commons Attribution 4.0 License. 10.31483/r-102465 102465 Генетические корреляции в оценке мутаций генов с доброкачественными образованиями кожи и меланомой (обзор литературы) Geneticheskie korreliatsii v otsenke mutatsii genov s dobrokachestvennymi obrazovaniiami kozhi i melanomoi (obzor literatury) Куницына Анастасия Владимировна Khambikova Anastasiia Vladimirovna nastya010994@mail.ru https://orcid.org/0000-0002-3686-9686 Антонова Елена Ивановна Antonova Elena Ivanovna antonov_67@mail.ru Давидюк Юрий Николаевич Davidiuk Iurii Nikolaevich davi.djuk@mail.ru Королева Анастасия Константиновна Koroleva Anastasiia Konstantinovna barashek00@gmail.com Ачилов Атабег Батырович Achilov Atabeg Batyrovich a.achilow@inbox.ru Научно-исследовательский центр фундаментальных и прикладных проблем биоэкологии и биотехнологии ФГБОУ ВО «Ульяновский государственный педагогический университет им. И.Н. Ульянова» Россия Nauchno-issledovatel'skii tsentr fundamental'nykh i prikladnykh problem bioekologii i biotekhnologii FGBOU VO "Ul'ianovskii gosudarstvennyi pedagogicheskii universitet im. I.N. Ul'ianova" Russia Научно-клинический центр прецизионной и регенеративной медицины ФГАОУ ВО «Казанский (Приволжский) федеральный университет» Россия Nauchno-klinicheskii tsentr pretsizionnoi i regenerativnoi meditsiny FGAOU VO "Kazanskii (Privolzhskii) federal'nyi universitet" Russia 52 64

диагностика и оценка кожных новообразований в большей части основана на гистопатологических критериях, тогда как в прогнозировании трансформации доброкачественных образований (невус) в меланому, а также в выявлении ранней стадии онкогенеза решающую роль играет оценка мутационного статуса пациента. Всесторонняя идентификация возможных прогностических биомаркеров экспрессируемых генов невус/меланома в полногеномных профилях позволит оценить злокачественный потенциал невуса и меланомы.

 меланома кожи невус NRAS CDKN2A гены: BRAF NF1 PTEN и KIT References Артамонова И.И. Клинико-морфологические особенности невусов / И.И. Артамонова, Е.В. Малютина // Известия Российской Военно-медицинской академии – 2019. – Т.1. – № S1. – С.16–18. Артамонова И. И. Малютина Е. В. Клинико-морфологические особенности невусов Известия Российской Военно-медицинской академии 2019 Т.1 Демидов Л.В. Подходы к диагностике и терапии меланомы кожи: эра персонализированной медицины / Л.В. Демидов, Утяшев И.А., Г.Ю. Харкевич // Consilium medicum (Приложение). – 2013. – №2–3. – С. 42–47. Демидов Л. В. Утяшев И. А. Харкевич Г. Ю. Подходы к диагностике и терапии меланомы кожи: эра персонализированной медицины Consilium medicum (Приложение) 2013 №2 42 47 Мазуренко Н.Н. Генетические особенности и маркеры меланомы кожи / Н.Н. Мазуренко // Успехи молекулярной онкологии. – 2014. – Т. 2. – С. 26–35. Мазуренко Н. Н. Генетические особенности и маркеры меланомы кожи Успехи молекулярной онкологии 2014 Т. 2 26 35 Соколикова В.Б. Отличительные морфологические и молекулярно-генетические особенности меланомы кожи и диспластических невусов / В.Б. Соколикова, Ю.В. Можинская, Е.М. Непомнящая  [и др.] // Молодой ученый. – 2016. – №15.2 (119.2). – С. 5–37. Соколикова В. Б. Можинская Ю. В. Отличительные морфологические и молекулярно-генетические особенности меланомы кожи и диспластических невусов Молодой ученый 2016 №15.2 (119.2) 5 37 Abbas O., Miller D.D., Bhawan J. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers // American journal of Dermatopathology. – 2014. – 36(5):363–79. Abbas O. Miller D. D. Bhawan J. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers American journal of Dermatopathology 2014 36(5):363 Alqathama A. BRAF in malignant melanoma progression and metastasis: potentials and challenges // American journal of cancer reseach. – 2020. – 10(4):1103–1114. Alqathama A. BRAF in malignant melanoma progression and metastasis: potentials and challenges American journal of cancer reseach 2020 10(4):1103 Bastian B.C. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia // Annual review of the Pathology. – 2014. – 9:239–71. Bastian B. C. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia Annual review of the Pathology 2014 9:239 Cancer Genome Atlas Network. Genomic classification of cutaneous melanoma // Cell. – 2015. – 161(7):1681–96. Cancer Genome Atlas Network. Genomic classification of cutaneous melanoma Cell 2015 161(7):1681 Chakraborty R., Wieland C.N., Comfere N.I. Molecular targeted therapies in metastatic melanoma // Pharmgenomics and personalized medicine. – 2013. – 6:49–56. Chakraborty R. Wieland C. N. Comfere N. I. Molecular targeted therapies in metastatic melanoma Pharmgenomics and personalized medicine 2013 6:49 Chhabra Y., Yong H.X.L., Fane M.E., Soogrim A., Lim W., Mahiuddin D.N., et al. Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells // Pigment cell and melanoma research. – 2018. – 31:51–63. Chhabra Y. Fane M. E. Soogrim A. Lim W. Mahiuddin D. N. Yong H.X.L.,,,,, et al. Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells Pigment cell and melanoma research 2018 31:51 Clark W.H., Elder D.E., Guerry D., Epstein M.N, Greene M.H, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma // Human Pathology. – 1984. – vol. 15, no. 12, pp. 1147–1165. Clark W. H. Elder D. E. Guerry D. Horn M. , Epstein M.N, Greene M.H, Van A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma Human Pathology 1984 vol. 15, no. 12, pp. 1147 Cust A.E., Drummond M., Kanetsky P.A., Goldstein A.M., Barrett J.H., MacGregor S., et al. Assessing the incremental contribution of common genomic variants to melanoma risk prediction in two population-based studies // The Journal of Investigative dermatology. – 2018. – 138:2617–24. Cust A. E. Drummond M. Kanetsky P. A. Goldstein A. M. Barrett J. H. ,,, MacGregor S., et al. Assessing the incremental contribution of common genomic variants to melanoma risk prediction in two population-based studies The Journal of Investigative dermatology 2018 138:2617 Dalmasso B., Ghiorzo P. Evolution of approaches to identify melanoma missing heritability // Expert review of molecular diagnostics. – 2020. – 20:523–31. Dalmasso B. Ghiorzo P. Evolution of approaches to identify melanoma missing heritability Expert review of molecular diagnostics 2020 20:523 Damsky W.E., Bosenberg M. Melanocytic nevi and melanoma: unraveling a complex relationship // Oncogene. – 2017. – 36(42):5771–5716. Damsky W. E. Bosenberg M. Melanocytic nevi and melanoma: unraveling a complex relationship Oncogene 2017 36(42):5771 Davies H., G.R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, et al.et al. Mutations of the BRAF gene in human cancer // Nature. – 2002. – 417:949–54. Davies H. Bignell G. R. Cox C. Stephens P. Edkins S. Clegg S. ,,,, et al. Mutations of the BRAF gene in human cancer Nature 2002 417:949 al.et Duffy D.L., Zhu G., Li X., Sanna M., Iles M.M., Jacobs L.C., et al. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways // Nature communications. – 2018. – 9:4774. Duffy D. L. Zhu G. Li X. Sanna M. Iles M. M. Jacobs L. C. ,,,, et al. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways Nature communications 2018 9:4774 Duffy D.L., Lee K.J., Jagirdar K., Pflugfelder A., Stark M.S., McMeniman E.K., et al. High nevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk // The British journal of Dermatology. – 2019. – 181:1009–16. Duffy D. L. Lee K. J. Jagirdar K. Pflugfelder A. Stark M. S. ,,, McMeniman E.K., et al. High nevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk The British journal of Dermatology 2019 181:1009 Duffy D.L., Jagirdar K., Lee K.J., McWhirter S.R., McMeniman E.K., De'Ambrosis B., et al. Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls // The Journal of Investigative dermatology. – 2020. – 140:498–501. Duffy D. L. Jagirdar K. Lee K. J. , McWhirter S.R., McMeniman E.K., De'Ambrosis B., et al. Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls The Journal of Investigative dermatology 2020 140:498 Elmore J.G., Barnhill R.L., Elder D.E., Longton G.M., Pepe M.S., Reisch L.M., et al. Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study // BMJ. – 2017. – 357:j2813. Elmore J. G. Barnhill R. L. Elder D. E. Longton G. M. Pepe M. S. Reisch L. M. ,,,, et al. Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study BMJ 2017 357:j2813 Glatz K., Hartmann C., Antic M., Kutzner H. Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis // American journal of Dermatopathology. – 2010. – 32:643–649. Glatz K. Hartmann C. Antic M. Kutzner H. , Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis American journal of Dermatopathology 2010 32:643 Gray-Schopfer V.C., Chong H., Chow J., Moss T., Abdel-Malek Z.A., Marais R., Wynford-Thomas D., Bennett D.C. et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? // British journal of cancer. – 2006. – Aug 21;95(4):496–505. Gray-Schopfer V. C. Chong H. Chow J. Moss T. Abdel-Malek Z. A. Marais R. Wynford-Thomas D. Bennett D. C. ,,,,, et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? British journal of cancer 2006 Aug 21; Griewank K.G., Murali R., Wiesner T. Molecular pathology and genomics of melanoma // Cutaneous Melanoma. 6 ed. Charm: Springer. – 2019. – 1–42. Griewank K. G. Murali R. Wiesner T. Molecular pathology and genomics of melanoma Cutaneous Melanoma. 6 ed. Charm: Springer 2019 1 Haenssle H.A., Mograby A., Ngassa A. et al. Association of patient risk factors and frequency of nevus-associated cutaneous melanomas // JAMA Dermatology. – 2016. – vol. 152, no. 3, pp. 291–298. Haenssle H. A. Mograby A. Ngassa A. et al. Association of patient risk factors and frequency of nevus-associated cutaneous melanomas JAMA Dermatology 2016 vol. 152, no. 3, pp. 291 Hayward N.K., Wilmott J.S., Waddell N., Johansson P.A., Field M.A., Nones K., et al. Whole-genome landscapes of major melanoma subtypes // Nature. – 2017. – 545:175–80. Hayward N. K. Wilmott J. S. Waddell N. Johansson P. A. Field M. A. Nones K. ,,,, et al. Whole-genome landscapes of major melanoma subtypes Nature 2017 545:175 Kim J.K., Nelson K.C. Dermoscopic features of common nevi: a review // Dermoscopy. – 2012. – 147(2):141–8. Kim J. K. Nelson K. C. Dermoscopic features of common nevi: a review Dermoscopy 2012 147(2):141 Krauthammer M., Kong Y., Bacchiocchi A., Evans P., et al. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas // Nature Genetics. – 2015. – 47:996–1002. Krauthammer M. Kong Y. Bacchiocchi A. Evans P. ,, et al. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas Nature Genetics 2015 47:996 Law M.H., Aoude L.G., Duffy D.L., Long G.V., Johansson P.A., Pritchard A.L., et al. Multiplex melanoma families are enriched for polygenic risk // Human Molecular Genetics. – 2020. – 29:2976–85. Law M. H. Aoude L. G. Duffy D. L. Long G. V. Johansson P. A. Pritchard A. L. ,,,, et al. Multiplex melanoma families are enriched for polygenic risk Human Molecular Genetics 2020 29:2976 Lee K.J., Janda M., Stark M.S., Sturm R.A., Soyer H.P. On Naevi and Melanomas: Two Sides of the Same Coin? // Frontiers in Medicine, – 2021. – 8:635316. Lee K. J. Janda M. Stark M. S. Sturm R. A. Soyer H. P. ,, On Naevi and Melanomas: Two Sides of the Same Coin? Frontiers in Medicine, 2021 8:635316 Lin W.M., Luo S., Muzikansky A. et al. Outcome of patients with de novo versus nevus-associated melanoma // Journal of the American Academy of Dermatology. – 2015. – vol. 72, no. 1, pp. 54–58. Lin W. M. Luo S. Muzikansky A. et al. Outcome of patients with de novo versus nevus-associated melanoma Journal of the American Academy of Dermatology 2015 vol. 72, no. 1, pp. 54 Mandala M., Merelli B., Massi D. NRAS in melanoma: targeting the undruggable target // Critical reviews in oncology/hematology. – 2014. -92(2):107–22. Mandala M. Merelli B. Massi D. NRAS in melanoma: targeting the undruggable target Critical reviews in oncology 2014 92(2):107 McMeniman E.K., Duffy D.L., Jagirdar K., Lee K.J., Peach E., McInerney-Leo A.M., et al. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls // The British journal of dermatology. – 2019. – 183:357–66. Duffy D. L. Jagirdar K. Lee K. J. Peach E. McMeniman E.K.,,,,, McInerney-Leo A.M., et al. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls The British journal of dermatology 2019 183:357 Menzies A.M. et al. Distinguishing clinicopathologic features of patients with V600E and V600K BRAF- mutant metastatic melanoma // Clinical Cancer Research. – 2012. – 18:3242–3249. Menzies A. M. et al. Distinguishing clinicopathologic features of patients with V600E and V600K BRAF- mutant metastatic melanoma Clinical Cancer Research 2012 18:3242 Michaloglou Ch., Vredeveld L., Soengas M.S., Denoyelle Ch., Kuilman T., et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi // Nature. – 2005. – 436(7051):720–4. Michaloglou Ch. Vredeveld L. Soengas M. S. Denoyelle Ch. Kuilman T. ,,, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi Nature 2005 436(7051):720 Mohammadpour A., Derakhshan M., Darabi H., Hedayat P., Momeni M. Melanoma: where we are and where we go. // Journal of Cellular Physiology. – 2019. – vol. 234, no. 4, pp. 3307–3320. Mohammadpour A. Derakhshan M. Darabi H. Hedayat P. Momeni M. ,, Melanoma Journal of Cellular Physiology 2019 vol. 234, no. 4, pp. 3307 Moretti S. et al. Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions // Journal Invest. Dermatology. – 1990. – 95:320–324. Moretti S. et al. Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions Journal Invest. Dermatology 1990 95:320 Pampena R., Kyrgidis A., Lallas A., Moscarella E., Argenziano G., Longo C. A meta-analysis of nevus-associated melanoma: Prevalence and practical implications // Journal of the American Academy of Dermatology. – 2017. – 77(5):938–945. Pampena R. Kyrgidis A. Lallas A. Moscarella E. Argenziano G. Longo C. ,,, A meta-analysis of nevus-associated melanoma: Prevalence and practical implications Journal of the American Academy of Dermatology 2017 77(5):938 Pozzobon F.C., Tell-Marti G., Calbet-Llopart N., Barreiro A., Espinosa N., Potrony M., et al. Influence of germline genetic variants on dermoscopic features of melanoma // Pigment Cell and Melanoma Research. – 2020. – 181:1009–16. Pozzobon F. C. Tell-Marti G. Calbet-Llopart N. Barreiro A. Espinosa N. Potrony M. ,,,, et al. Influence of germline genetic variants on dermoscopic features of melanoma Pigment Cell and Melanoma Research 2020 181:1009 Rayner J.E., McMeniman E.K., Duffy D.L., De'Ambrosis B., Smithers B.M., Jagirdar K., et al. IRF4 rs12203592*T/T genotype is associated with nodular melanoma // Melanoma Research. – 2019. – 29:445–6. Rayner J. E. Duffy D. L. Smithers B. M. Jagirdar K. McMeniman E.K.,, De'Ambrosis B.,,, et al. IRF4 rs12203592*T Melanoma Research 2019 29:445 Rayner J.E., McMeniman E.K., Duffy D.L., De'Ambrosis B., Smithers B.M., Jagirdar K., et al. Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients // Journal of the European Academy of Dermatology and Venereology. – 2019. – 33:1076–83. Rayner J. E. Duffy D. L. Smithers B. M. Jagirdar K. McMeniman E.K.,, De'Ambrosis B.,,, et al. Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients Journal of the European Academy of Dermatology and Venereology 2019 33:1076 Rayner J.E., Duffy D.L., Smit D.J., Jagirdar K., Lee K.J., De'Ambrosis B., et al. Albinism variants in individuals with amelanotic/hypomelanotic melanoma: increased carriage of TYR and OCA2 variants // PLoS ONE. – 2020. – 15:e0238529. Rayner J. E. Duffy D. L. Smit D. J. Jagirdar K. Lee K. J. ,,, De'Ambrosis B., et al. Albinism variants in individuals with amelanotic PLoS ONE 2020 15:e0238529 Roh M.R., Eliades Ph., Gupta S., Tsao H. Genetics of Melanocytic Nevi // Pigment Cell Melanoma Res. – 2015. – Nov. 28(6): 661–672. Roh M. R. Eliades Ph. Gupta S. Tsao H. , Genetics of Melanocytic Nevi Pigment Cell Melanoma Res 2015 Nov. 28(6): 661 Saginala K., Barsouk A., Aluru J.S., Rawla P., Barsouk A. Epidemiology of Melanoma // Epidemiology of Melanoma. Med. Sci. – 2021. – 9: 63. Saginala K. Barsouk A. Aluru J. S. Rawla P. ,, Epidemiology of Melanoma Epidemiology of Melanoma. Med. Sci 2021 9: 63 Schadendorf D., van Akkooi A.C.J., Berking C. et al. Melanoma. // The Lancet. – 2018. – vol. 392, no. 10151, pp. 971–984. Schadendorf D. Berking C. van Akkooi A.C.J., et al. Melanoma The Lancet 2018 vol. 392, no. 10151, pp. 971 Shain A.H., Yeh I., Kovalyshyn I. et al. The genetic evolution of melanoma from precursor lesions // The New England Journal of Medicine. – 2015. – vol. 373, no. 20, pp. 1926–1936. Shain A. H. Yeh I. Kovalyshyn I. et al. The genetic evolution of melanoma from precursor lesions The New England Journal of Medicine 2015 vol. 373, no. 20, pp. 1926 Shain A.H., Bastian B.C. From melanocytes to melanomas // Nature reviews Cancer. – 2016. – 16:345–58. Shain A. H. Bastian B. C. From melanocytes to melanomas Nature reviews Cancer 2016 16:345 Shain A.H., Joseph N.M., Yu R., Benhamida J., Liu S., Prow T., et al. Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution // Cancer Cell. – 2018. – 34:45–55. Shain A. H. Joseph N. M. Yu R. Benhamida J. Liu S. Prow T. ,,,, et al. Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution Cancer Cell 2018 34:45 Shitara D., Nascimento M.M., Puig S., Yamada S., Enokihara M.M., Michalany N., et al. Nevus-associated melanomas: clinicopathologic features //Am Journal Clinical Pathology – 2014. – 142:485–491. Shitara D. Nascimento M. M. Puig S. Yamada S. Enokihara M. M. Michalany N. ,,,, et al. Nevus-associated melanomas: clinicopathologic features Am Journal Clinical Pathology 2014 142:485 Shitara D., Tell-Martí G., Badenas C. et al. Mutational status of naevus-associated melanomas // The British Journal of Dermatology – 2015 – vol. 173, no. 3, pp. 671–680. Shitara D. Tell-Martí G. Badenas C. et al. Mutational status of naevus-associated melanomas The British Journal of Dermatology 2015 vol. 173, no. 3, pp. 671 Siegel R.L., Miller K. D., Jemal A. Cancer statistics // Cancer Journal for Clinicians – 2020. – vol. 70, no. 1, pp. 7–30. Siegel R. L. Miller K. D. Jemal A. Cancer statistics Cancer Journal for Clinicians 2020 vol. 70, no. 1, pp. 7 Srivastava S., Ghosh S., Kagan J., Mazurchuk R. The PreCancer Atlas (PCA) // Trends Cancer. – 2018. – 4:513–4. Srivastava S. Ghosh S. Kagan J. Mazurchuk R. , The PreCancer Atlas (PCA) Trends Cancer 2018 4:513 Stark M.S., Tan J.M., Tom L., Jagirdar K., Lambie D., Schaider H., et al. Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms // The journal of investigative dermatology. – 2018. – 138:1636–44. Stark M. S. Tan J. M. Tom L. Jagirdar K. Lambie D. Schaider H. ,,,, et al. Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms The journal of investigative dermatology 2018 138:1636 Stark M.S., Denisova E., Kays T.A., Heidenreich B., Rachakonda S., Requena C., et al. Mutation signatures in melanocytic nevi reveal characteristics of defective DNA repair // The journal of investigative dermatology. – 2020. – 140:2093–6. Stark M. S. Denisova E. Kays T. A. Heidenreich B. Rachakonda S. Requena C. ,,,, et al. Mutation signatures in melanocytic nevi reveal characteristics of defective DNA repair The journal of investigative dermatology 2020 140:2093 Tan J.M., Tom L.N., Jagirdar K., Lambie D., Schaider H., Sturm R.A., et al. The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation // British Journal of Dermatology. – 2018. – 178:191–7. Tan J. M. Tom L. N. Jagirdar K. Lambie D. Schaider H. Sturm R. A. ,,,, et al. The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation British Journal of Dermatology 2018 178:191 Tan J.M., Tom L.N., Soyer H.P., Stark M.S. Defining the molecular genetics of dermoscopic naevus patterns // Dermatology. – 2019. – 235:19–34. Tan J. M. Tom L. N. Soyer H. P. Stark M. S. , Defining the molecular genetics of dermoscopic naevus patterns Dermatology 2019 235:19 Tang J., Fewings E., Chang D., Zeng H., Liu S., Jorapur A., et al. The genomic landscapes of individual melanocytes from human skin // Nature. – 2020. -586:600–5. Tang J. Fewings E. Chang D. Zeng H. Liu S. Jorapur A. ,,,, et al. The genomic landscapes of individual melanocytes from human skin Nature 2020 586:600 Wang D.G., Xu X.H., Ma H.J., et al. Stem cell factor combined with matrix proteins regulates the attachment and migration of melanocyte precursors of human hair follicles in vitro // Biological and pharmaceutical bulletin – 2013. – 36:1317–25. Wang D. G. Xu X. H. Ma H. J. , et al. Stem cell factor combined with matrix proteins regulates the attachment and migration of melanocyte precursors of human hair follicles in vitro Biological and pharmaceutical bulletin 2013 36:1317 Wei Han, Xu W.-H., Wang J.-X., Hou J.-M., Zhang H.-L., Zhao X.-Y., Shen G.-L., et al. Identification, Validation, and Functional Annotations of Genome-Wide Profile Variation between Melanocytic Nevus and Malignant Melanoma // BioMed Research International. – 2020. – Aug 31; 2020:1840415. Wei Han, Xu W.-H., Wang J.-X., Hou J.-M., Zhang H.-L., Zhao X.-Y., Shen G.-L., et al. Identification, Validation, and Functional Annotations of Genome-Wide Profile Variation between Melanocytic Nevus and Malignant Melanoma BioMed Research International 2020 Aug 31; Whiteman D.C. et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma // Journal of the National Cancer Institute. – 2003. – 95: 806–812. Whiteman D. C. et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma Journal of the National Cancer Institute 2003 95: 806 Whiteman D.C., Pavan W.J., Bastian B.C. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin // Pigment Cell and Melanoma Research. – 2011. – 24:879–97. Whiteman D. C. Pavan W. J. Bastian B. C. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin Pigment Cell and Melanoma Research 2011 24:879 Yeh I., von Deimling, B.C. Bastian Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia // Journal of the National Cancer Institute – 2013. – 105:917–919. Yeh I. Deimling B. C. von Bastian Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia Journal of the National Cancer Institute 2013 105:917